Enterome raises €5.5m funding to validate biomarkers; Fasting blood glucose signals depression in elderly;

> Paris-based biomarker company Enterome has raised €5 million ($6.6 million) to validate its biomarkers and help move them toward diagnostic tests. Article

> A panel of 10 serum biomarkers could support CT screening in diagnosis of lung cancer in high-risk people. Article

> Fasting blood glucose signals more than diabetes; it could diagnose depression in elderly people. Article (sub. req.)

> The leukocyte-based biomarker BORIS is in a trial as a potential early breast cancer biomarker in women with high familial risk of the disease. Article

> Qiagen and the Bio-X Center of Shanghai Jiao Tong University are to set up a translational medicine base in Shanghai; the projects will include biomarker validation. Article

> An ER stress biomarker could pick up diabetes before symptoms start, if mouse model findings transfer across to the clinic. Press release

> Soluble CD14, a biomarker in babies' umbilical cord blood, could signpost their risk of cough and wheeze at one year. Article

> A new method to measure beta amyloid, using flow cytometry, could help develop Alzheimer's disease drugs and diagnostics. Press release

> Magnetic resonance imaging can "see" the oncometabolite 2-hydroxyglutarate; this technique could have potential in brain tumor diagnosis. Press release | Abstract

> Troponin-I assay could predict risk of cardiovascular death up to 15 years in the future. Press release

> New autism mouse model has suggested a link between early disruptions in serotonin signaling in the brain and autism spectrum disorder. Press release

> Levels of granulocyte colony-stimulating factor (G-CSF) could be a biomarker for the severity of stroke. Abstract

And Finally… State wealth could be linked with cardiac biomarkers. Article

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.